#MPNSM
LightNews LightNews
pedshemedoc.bsky.social
Thinking of all those living with rare diseases on #RareDiseaseDay 🌈🦓#FunEarringFriday #mpnsm
February 28, 2025 at 12:52 PM
drmiguelperales.bsky.social
On my way to @ash-hematology.bsky.social #ASH24 & sharing this starterpack for HCT, #CARTcells & #genetherapy - > 100 members DM/comment if I missed someone #bmtsm #mmsm #leusm #lymsm #sicklecell #mpnsm #medsky

go.bsky.app/7xxh8WW
December 5, 2024 at 12:32 PM
kmirza.bsky.social
What story does this bone marrow tell you? #leusm #mdssm #mpnsm #hemepath
February 25, 2025 at 1:30 AM
bloodgenes.bsky.social
Enjoyed writing this commentary with @g-agarwal.bsky.social for @bloodjournal.bsky.social: ashpublications.org/blood/articl...

Covers an exciting paper from Tapper and co: ashpublications.org/blood/articl...

#mpnsm
December 26, 2025 at 6:05 PM
hemedoc.bsky.social
#ASCO25 #mpnsm Arce-Ruiz: Macular degeneration in pts w clonal hematopoiesis.
May 30, 2025 at 7:21 PM
mpndoc.bsky.social
Super proud of Oh Lab members Molly Brakhane & Fan He presenting at #ASH24! 🤩

Both are recipients of @ash-hematology.bsky.social abstract achievement awards! 🥳

#mpnsm #ASHkudos
December 5, 2024 at 5:16 AM
mullallylab.bsky.social
After a fantastic MGR today, we are thrilled to welcome Dr. Ross Levine back for our #hematology seminar tomorrow - very thankful to Ross for such & engaging & fun visit! #MPNsm @stanforddeptmed.bsky.social @rosslevinemd.bsky.social @mskcancercenter.bsky.social
stanford-heme.bsky.social Stanford Hematology Division @stanford-heme.bsky.social · Apr 8
✨Thrilled to welcome the esteemed Dr. Ross L. Levine for a captivating presentation at the Breakthroughs in Hematology seminar tomorrow!✨

@rosslevinemd.bsky.social @stanforddeptmed.bsky.social l @mskcancercenter.bsky.social
April 9, 2026 at 12:32 AM
mullallylab.bsky.social
Really enjoyed participating in this podcast @bloodjournals.hematology.org on new #targetedtherapies in #MPN including #mutantcalreticulin #MPNsm @stanforddeptmed.bsky.social @ash.hematology.org @mpnrf.bsky.social @stanfordmedicine.bsky.social
April 2, 2026 at 7:41 PM
jdbeckman.bsky.social
So proud of my trainees in #SCD and #MPNSM (missing pic of @ash.hematology.org HIP mentee) presenting their hard work at #ASH2025
December 7, 2025 at 3:28 PM
anand-88-patel.bsky.social
Very excited to see the #mpnsm oral session kick off! #ASH24
December 7, 2024 at 10:01 PM
onclive.bsky.social
Rusfertide Meets Response End Point in Phlebotomy-Dependent Polycythemia Vera
#MPNsm #hematology #oncology
www.onclive.com/view/rusfert...
Rusfertide Meets Response End Point in Phlebotomy-Dependent Polycythemia Vera
Rusfertide improved responses vs placebo in phlebotomy-dependent polycythemia vera.
www.onclive.com
March 3, 2025 at 5:56 PM
vjhemonc.bsky.social
We're so excited for our Post-ASH 2024 Highlights Webinar Series!🩸

Presentations & discussions on selected abstracts from #ASH24

Featuring leading #HemOnc experts

👉https://ow.ly/zc9Z50U6Nkp

#LeuSM #MPNsm #MMsm #LymSM #MDSsm
November 28, 2024 at 11:28 AM
mullallylab.bsky.social
Congrats, Ruben! Very well deserved #MPNsm
rubenmesamd.bsky.social Ruben A. Mesa, MD, FACP @rubenmesamd.bsky.social · Jun 18
Honored & humbled to receive #BeutlerPrize along w/#RadekSkoda. Measuring #MPN Symptoms & developing the 4 JAKi = #TEAM of dedicated MPN Patients/Investigators/#PharmaColleagues @harrisoncn1 #SergeVerstovsek @jjkiladjian #Vannuchi @RobynScherber #JoyceNiblack @wakeforestmed
June 18, 2025 at 4:11 PM
mtmdphd.bsky.social
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients [Sep 6, 2023] @benwteh et al. @TheLancetInfDis doi.org/10.1016/S147... #IDonc #leusm #lymsm #mmsm #mpnsm #caxtx
Redirecting
doi.org
November 18, 2024 at 7:05 PM
nicogagelmann.bsky.social
🎉Finally out🎉

Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for Myelofibrosis in Am J Hematol

👉using JAK inhibitors until engraftment is safe
👉 improved efficacy signals (excellent engraftment, reduced acute GVHD)
onlinelibrary.wiley.com/doi/full/10....
#mpnsm #medsky
November 18, 2024 at 7:07 AM
rubenmesamd.bsky.social
#ASH24 MPN Therapy session - FREEDOM2 results show stable to increasing platelets in those with 50-100x10(9)/L at baseline validating JAKARTA/JAKARTA2 results! Takeaway-safety and efficacy for MF with “low” platelets @bmsnews #MPNSM @LevineCancer @WakeCancer
December 8, 2024 at 5:57 PM
hemedoc.bsky.social
#ASCO25 #mpnsm Andorsky: Asciminib in 2L CML (wo T315I), n=101, treatment ongoing in 91%. 82.5% achieved BCR-ABL <0.1%, 44% MMR at 24wks. Only 3% had AEs leading to discontinuation. Study ongoing.
May 30, 2025 at 7:19 PM
drkomanduri.bsky.social
Wow. The hematologist in me no longer feels out of my element as the #ASCO25 plenary moves to a trial of polycythemia vera (Rusfertide vs CSC, the VERIFY Study). #mpnsm #hematology
June 1, 2025 at 7:17 PM
drkomanduri.bsky.social
Conclusion slide by Dr. Andrew Kuykendall on VERIFY Rusfertide study for patients with PCV. Meaningful impacts on transfusion requirements and patient reported outcomes demonstrated in this pivotal study. #hematology #ASCO25 #polycythemiavera #mpnsm
June 1, 2025 at 7:24 PM
hemedoc.bsky.social
#ASCO25 #mpnsm Mascarenhas: Imetelstat + Ruxolitinib in Int1/2- and HR-MF.
May 30, 2025 at 7:06 PM
mullallylab.bsky.social
Honored to contribute to @bloodjournals.hematology.org "New Wave of Targeted Therapies in #MPN" review series curated by Dr. Jason Gotlib, thankful to my awesome co-author Dr. Gabriel Salzman! Article link: lnkd.in/gBjUi4R9
@stanforddeptmed.bsky.social @ash.hematology.org @mpnrf.bsky.social #MPNsm
March 19, 2026 at 10:18 PM
mtmdphd.bsky.social
COVID‐19 vaccine effectiveness in patients with hematologic malignancy [May 18, 2022] @DrDimpyShah @Dr_Pankil_Shah @mtmdphd Transplant ID onlinelibrary.wiley.com/doi/10.1111/... #COVID19Vaccine #COVID19nCancer #bmtsm #leusm #lymsm #mmsm #mpnsm #IDonc
January 26, 2025 at 4:05 PM
karintourmente.bsky.social
Entendu sur @franceinter.fr : « Le corps est un traître » - Marc Dugain
#MPNsm
November 29, 2024 at 8:48 AM
vjhemonc.bsky.social
How can clinicians identify patients with MPNs whose disease is in the accelerated or blast phase? 🩸

🎥 @anand-88-patel.bsky.social shares insight into this in an interview from the #MPNWorkshop2025:

👉 buff.ly/ygLFHa4 👈

#MPNsm #HemOnc #MedSky #HemeSky #BloodSky
October 2, 2025 at 9:00 AM
rubenmesamd.bsky.social
#MPNSM off and running at #ASH24. Important results from #Spanish #ET registry -achieving CHR (vs not) with 1L hydroxyurea superior for thrombosis and progression ⁦‪@MPN_Hub‬⁩ ⁦‪@MPN_RF‬⁩ ⁦‪@doctorpemm‬⁩ ⁦‪@LevineCancer‬⁩ ⁦‪@WakeCancer‬⁩
December 7, 2024 at 10:15 PM